针对微生物群-miRNA-蛋白酶轴:在黑色素瘤中,这是一个新的治疗途径
Elias N Katsoulieris1, Paraskevi Ioannou1, Nikolaos A Afratis1,2
1Laboratory of Biotechnology and Molecular Analysis, Department of Agricultural Development, Agri-food & Management of Natural Resources, National and Kapodistrian University of Athens, Evia, Greece.
The FEBS journal
|January 8, 2026
概括
本综述探讨了微RNAs (miRNAs) 如何调节细胞外矩阵 (ECM) 蛋白酶,影响黑色素瘤转移. 它还研究了肠道微生物群,miRNA和黑色素瘤进展之间的联系,提出了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 黑色素瘤转移严重依赖于细胞外矩阵 (ECM) 周转率的调节.
- ECM蛋白酶在ECM降解中发挥关键作用,影响黑色素瘤细胞生长,迁移,入侵和免疫逃避.
- 复杂的转录和后转录调节机制在黑色素瘤进展期间控制ECM蛋白酶活性.
研究的目的:
- 审查表观遗传机制,特别是微RNA (miRNA) 在向ECM蛋白酶转录中的作用.
- 检查肠道失生症对miRNA配置文件的影响及其与黑色素瘤进展和免疫疗法耐药性的联系.
- 评估向ECM蛋白酶和调节肠道微生物群的治疗潜力,以治疗黑色素瘤.
主要方法:
- 文献综述侧重于黑色素瘤中miRNAs对ECM蛋白酶的表观遗传调节.
- 分析了将肠道微生物群失调与改变的miRNA表达和黑色素瘤进展联系在一起的研究.
- 评估涉及miRNA向和肠道微生物群调节的治疗策略.
主要成果:
- 微RNA直接准ECM蛋白酶转录,显著影响黑色素瘤细胞的行为和进展.
- 肠道失生症与改变的矩阵金属蛋白酶向的miRNA配置文件相关,有助于黑色素瘤抵抗免疫疗法.
- 肠道微生物群的调节和直接的miRNA向显示了作为黑色素瘤辅助疗法的希望.
结论:
- 由miRNAs进行表观遗传调节是通过ECM蛋白酶调节导致黑色素瘤转移的关键因素.
- 肠道微生物群通过miRNA介导的途径影响黑色素瘤的进展和免疫治疗反应.
- 通过miRNA针对肠道微生物群和ECM蛋白酶的联合策略为黑色素瘤提供了创新的治疗途径.
相关概念视频
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


